Anti-CPVL Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody targeting human CPVL (carboxypeptidase, vitellogenic-like), validated for Western blot.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential
UniProt
Q9H3G5
Size
100ug
Cat. #
RP2CPVL

In stock

SKU
RP-CPVL

Options

As low as: $130.00

Target Overview

CPVL (carboxypeptidase, vitellogenic-like; UniProt Q9H3G5) is a probable serine carboxypeptidase (EC 3.4.16.-) belonging to the vitellogenic carboxypeptidase family. The 476-amino acid protein is implicated in lysosomal processing pathways, where it may participate in the digestion of phagocytosed particles, inflammatory protease cascades, and trimming of peptides for antigen presentation. Also designated vitellogenic carboxypeptidase-like protein (VCP-like protein, hVLP), CPVL exhibits structural and functional features consistent with lysosomal serine carboxypeptidases, though its precise substrate repertoire remains incompletely characterized. Researchers studying innate immunity, antigen processing, and lysosomal biology have identified CPVL expression in macrophages and other phagocytic cells, where its enzymatic activity may influence both proteolytic cascades and peptide repertoires presented on MHC molecules. Recent work has further connected CPVL to tumor microenvironment heterogeneity and metastatic signaling, particularly in osteosarcoma and triple-negative breast cancer contexts.

Background

CPVL functions as a probable serine carboxypeptidase with roles spanning lysosomal proteolysis, inflammation, and adaptive immunity. Its predicted involvement in trimming peptides for antigen presentation positions CPVL within the molecular machinery that shapes immune surveillance and T-cell recognition. Expression in macrophages has drawn attention in cancer biology: Wang et al. (2024) demonstrated that CPVL-expressing macrophages correlate with prognosis in triple-negative breast cancer, suggesting functional contributions to tumor-associated immune populations. The protein's propeptide domain, used as the immunogen for Triple Point Biologics' catalog offerings, is thought to regulate enzyme activation in a manner analogous to other procarboxypeptidases. In osteosarcoma, Wang et al. (2023) reported that CPVL promotes proliferation and metastasis through the TGF-β/Smad signaling pathway, linking carboxypeptidase activity to canonical oncogenic cascades. Additional studies have implicated CPVL in gastric cancer heterogeneity and metabolic interplay within the tumor microenvironment, underscoring its relevance beyond classical immune contexts. Proteomic screens have also identified CPVL in urine biomarker panels for mild cognitive impairment and Alzheimer's disease, though the mechanistic connection to neurodegeneration remains under investigation. Three domain-specific rabbit polyclonal clones (RP1CPVL, RP2CPVL, RP3CPVL) are available, all raised against the propeptide domain and validated for Western blot. These reagents support investigations of CPVL expression, localization, and proteolytic processing across diverse tissue and disease contexts.

References

  1. Wang X et al (2024) Single-cell Atlas reveals core function of CPVL/MSR1 expressing macrophages in the prognosis of triple-negative breast cancer. Front Immunol. PubMed · DOI
  2. Wang L et al (2023) Carboxypeptidase Vitellogenic-Like Promotes the Proliferation and Metastasis of Osteosarcoma through the TGF-β/Smad Signaling Pathway. Ann Clin Lab Sci. PubMed
  3. Lin X et al (2024) Dissecting gastric cancer heterogeneity and exploring therapeutic strategies using bulk and single-cell transcriptomic analysis and experimental validation of tumor microenvironment and metabolic interplay. Front Pharmacol. PubMed · DOI
  4. Wang Y et al (2023) Identification of novel diagnostic panel for mild cognitive impairment and Alzheimer's disease: findings based on urine proteomics and machine learning. Alzheimers Res Ther. PubMed · DOI

Additional Specifications

Gene Symbol CPVL
UniProt ID Q9H3G5
Host Species Rabbit
Species Reactivity Validated- Human
Potential
Pack Size 100ug
Immunogen (Propeptide domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 23-62.
Immunogen (Catalytic domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 23-476.
Immunogen (Carboxyterminal end)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 426-476.
Alternate Names CPVL, Probable serine carboxypeptidase CPVL, Carboxypeptidase, vitellogenic-like, Vitellogenic carboxypeptidase-like protein, VCP-like protein, hVLP, EC 3.4.16.-

Frequently Asked Questions

What molecular weight should I expect for CPVL on a Western blot?

The unprocessed CPVL polypeptide is 476 amino acids with a calculated mass near 54 kDa. In practice, the protein is N-glycosylated and proteolytically processed during transit through the secretory pathway to lysosomes, so the apparent migration on SDS-PAGE typically falls between 54 and 60 kDa for the proform, with smaller mature fragments sometimes visible after lysosomal maturation. PNGase F treatment will collapse the upper band. If you see only a ~50 kDa species in lysosomal fractions, that is consistent with the processed mature enzyme rather than nonspecific signal.

Which cell types or tissues are good positive controls for CPVL?

CPVL is most abundantly expressed in myeloid cells, particularly monocytes and macrophages. Reliable positive controls include THP-1 cells (especially after PMA differentiation), primary human monocyte-derived macrophages, U937 cells, and dendritic cell preparations. Among tissues, spleen, lung, and placenta lysates give detectable signal. HEK293 and most epithelial lines express CPVL at low or undetectable levels and are useful as low-expression comparators rather than negative controls. For overexpression validation, transient transfection of a full-length CPVL construct in HEK293T provides a clear reference band.

What is a good starting dilution for Western blot with this antibody?

Start at 1:1000 in 5% non-fat milk or BSA in TBST, overnight at 4°C, with 20-30 µg of total lysate per lane. For low-expressing samples, increase loading rather than antibody concentration first. If background is high in macrophage lysates, switch the blocking buffer to 5% BSA and extend washes. The lot has been validated for WB; titrate within a 1:500 to 1:2000 window against your specific lysate to balance signal and background. Use freshly prepared reducing sample buffer because the disulfide-linked processed form can give doublets under partial reduction.

Does this antibody work for IHC and IF, and at what dilution?

The antibody is brand-validated for IHC and immunofluorescence, but lot-specific dilutions for those applications are not certified on this datasheet. For FFPE IHC, heat-induced epitope retrieval in citrate buffer (pH 6.0) is a reasonable first condition, with primary antibody titrated between 1:100 and 1:500. For IF on fixed macrophages, 4% PFA fixation followed by 0.1% Triton X-100 permeabilization preserves the punctate lysosomal staining pattern expected for CPVL. Co-stain with LAMP1 or LAMP2 to confirm lysosomal localization. Titrate against a known positive sample before committing to a large experiment.

Will this antibody cross-react with mouse or rat CPVL?

Reactivity is validated only against human CPVL. Human and mouse CPVL share roughly 80% sequence identity across the mature region, so cross-reactivity with mouse is plausible but has not been confirmed in-house and should be considered predicted at best. If you intend to use the antibody on mouse macrophages or rodent tissue, run a side-by-side blot with a known human-positive control (PMA-differentiated THP-1) and your rodent sample, and confirm the band with a CPVL-knockout or siRNA-depleted control before drawing conclusions.

How should I prepare lysates to preserve CPVL signal?

CPVL is a lysosomal protein, so use a lysis buffer that efficiently solubilizes membrane-bound and luminal lysosomal content. RIPA buffer supplemented with protease inhibitors works well; for native or activity studies use a milder NP-40 or Triton X-100 buffer at pH 7.4. Avoid prolonged incubation at room temperature, since endogenous lysosomal proteases released during lysis can clip CPVL and generate lower molecular weight fragments. Boil samples at 95°C for 5 minutes in reducing Laemmli buffer immediately after lysis. For macrophage samples, briefly sonicate to shear genomic DNA and reduce viscosity.

What controls should I include to confirm band specificity?

Three controls strengthen specificity claims for CPVL. First, an siRNA or shRNA knockdown in THP-1 or primary macrophages should reduce the band at ~54-60 kDa. Second, parallel running of a CPVL overexpression lysate (HEK293T transfected with full-length CPVL) provides a positive reference at the expected size. Third, a low-expressing line such as HeLa or untransfected HEK293 serves as a near-negative comparator. Pre-adsorption with the immunizing antigen, if available, is the cleanest specificity test. Always run a loading control on the same membrane rather than a stripped reblot when quantifying.

How should I store the antibody and how stable is it?

Store the antibody at -20°C upon receipt for long-term storage. After the first thaw, aliquot into low-binding tubes in 10-20 µL volumes to avoid repeated freeze-thaw cycles, which are the most common cause of titre loss for rabbit polyclonals. Working aliquots can be kept at 4°C for up to two weeks if sodium azide is present in the formulation; do not add azide if you plan to use the antibody with HRP-conjugated secondaries in the same incubation. Avoid frost-free freezers, which cycle temperature and degrade antibody activity over time.

Validation imagery coming soon

Western blot validation figures for RP-CPVL will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

Also known as:

  • CPVL
  • Probable serine carboxypeptidase CPVL
  • Carboxypeptidase
  • vitellogenic-like
  • Vitellogenic carboxypeptidase-like protein
  • VCP-like protein
  • hVLP
  • EC 3.4.16.-
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →